rasagiline has been researched along with Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bejar, C; Finberg, JP; Gross, A; Poltyrev, T; Wang, RH; Weinstock, M; Youdim, MB | 1 |
| Bejar, C; Kirschbaum-Slager, N; Lazarovici, P; Shoham, S; Weinstock, M; Youdim, MB | 1 |
2 other study(ies) available for rasagiline and Brain Injuries
| Article | Year |
|---|---|
TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain Injuries; Cholinesterase Inhibitors; Indans; Male; Memory Disorders; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Scopolamine | 2000 |
Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs.
Topics: Alzheimer Disease; Animals; Anti-Bacterial Agents; Brain Injuries; Cell Death; Cell Hypoxia; Cholinesterase Inhibitors; Cholinesterases; Indans; Male; Memory; Mice; Monoamine Oxidase; Neuroprotective Agents; PC12 Cells; Rats; Rats, Sprague-Dawley; Reaction Time; Streptozocin | 2001 |